One-Day Online Cognitive Behavioral Therapy-Based Workshops for the Prevention of Postpartum Depression: A Randomized Controlled Trial. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Background: Postpartum depression (PPD) affects up to 1 in 5 birthing parents and is associated with more future depressive episodes. We aimed to determine if PPD could be prevented with online 1-day cognitive behavioral therapy (CBT)-based workshops. Methods: This randomized controlled trial enrolled pregnant persons at 28-38 weeks gestation at increased risk for PPD, living in Ontario and free of current DSM-5 major depressive disorder (MDD). Participants received the workshop plus treatment as usual (TAU; experimental group) or TAU alone (control group). We assessed MDD diagnosis, levels of PPD symptoms, anxiety, social support, mother-infant relationship, and infant temperament at 1, 2, and 3 months postpartum. The primary outcome was MDD at 3 months postpartum assessed using the Mini-International Neuropsychiatric Interview. Results: Since <10% of participants developed MDD, trial recruitment was stopped early. Data were collected up to 2 months postpartum in those already enrolled. Among these participants (n = 124), reductions in Edinburgh Postnatal Depression Scale (EPDS) scores were seen in the experimental group at 2 months but were not statistically significant (P = .06). Higher risk participants (baseline EPDS ≥7) in the experimental group showed larger, statistically significant reductions (P<.05) in PPD and anxiety at 2 months postpartum. Limitations: Eligibility criteria resulted in a sample that did not develop MDD at rates high enough to continue the trial and limited study statistical power. Conclusions: Definitive conclusions regarding the effectiveness of online 1-day workshops for preventing PPD are not possible, but these results may warrant future testing with a higher risk sample. Trial Registration: ClinicalTrials.gov identifier: NCT05753176.

authors

  • Boland, Zoe
  • Lloyd, Nancy
  • Drage, Jaslyn
  • Serrano-Lomelin, Jesus
  • Bieling, Peter
  • Streiner, David
  • Van Lieshout, Ryan J

publication date

  • April 16, 2025